Global Epigenetics Market By Product Overview
Introduction:
Epigenetics is the study of heritable changes in gene expression that do not involve changes to the underlying DNA sequence. Further, the epigenetic change is a regular and natural occurrence but can be influenced by several factors, which include age, lifestyle, environment, and disease stage. Epigenetics is the study of heritable changes in gene expression that can change an organism’s appearance or biological functions without changing the actual DNA sequence. At molecular level epigenetics refers to the addition or deletion of a methyl group to a DNA base turning the gene on or off. Additionally, packaging of the chromatin structure by silencing or opening regions of the genome by winding or unwinding the DNA around histones. Epigenetics therapy are used for treatment of several diseases such as alzheimer’s disease, respiratory disease, cancer, heart disease, mental illnesses, and diabetes. Epigenetics Market size was valued at about USD 2.5 Billion in 2024 and expected to grow at CAGR of 18.7% to extend a value of USD 11.9 Billion by 2034.
Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.
Global Epigenetics Market By Product Dynamics
Increasing number of applications
Increasing number of applications of epigenetics in the research field and rising research activities on epigenetics by various research organizations & institutes across the globe are expected to boost demand for epigenetics over the forecast period. For instance, in 2019, according to data published by National Institute of Environmental Health Science (NIEHS), is currently supporting epigenetics research that accelerates the understanding of human biology and the role of the environment in disease. Furthermore, rising supportive government initiatives and surge funding for epigenetics research is expected to augment growth of the global epigenetics market in near future.
Rising prevalence of cancer
Moreover, rising prevalence of cancer and others disease across the globe is also factor which in turn is expected to create demand for global epigenetics market over the forecast period. For instance, in 2018, according to data published by National Cancer Institute, the number of new cancer cases per year is expected to rise to 23.6 Mn by 2030. However, high costs associated with instruments and lack of skilled personnel are major factors expected to restrain the global epigenetics market growth over the forecast period.
Increasing research and development
Increasing research and development in the field of epigenetics is expected to foster the global epigenetics market. Furthermore, the implementation of epigenetics for oncology research is estimated to augment the epigenetics market. Additionally, the government initiatives to encourage the research are also expected to favor the growth of epigenetics market. Moreover, the organic and inorganic growth strategies such as collaboration, merger, acquisition and product launch by the market players is also expected to propel the epigenetics market.
However, high maintenance and high cost of instruments, which include qPCR or next generation sequencing implemented for epigenetic study are expected to hamper the epigenetics market.
Global Epigenetics Market By Product Segmentation
For detailed understanding of market dynamics, the global epigenetics market is analyzed across key regions viz North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Each of these regions is analyzed on the basis of market findings across major countries in these regions for a macro-level understanding of the global market. In 2018, North America market dominates the global epigenetics market in terms of revenue as compared to other regions. This is owing to well-developed healthcare infrastructure, increasing incidence of cancer and other diseases. Further, high adoption of advance technologies and favorable government funding in the region also fosters the market. Europe market accounts for second-largest revenue share contribution to the global epigenetics market, followed by markets in the Asia Pacific, Latin America, and the Middle East & Africa respectively. The market in the Asia Pacific is anticipated to register comparatively faster growth in terms of revenue over the forecast period. This can be attributed owing to increasing number of research institutes, rising prevalence of cancer and other diseases, and rising healthcare expenditure in the region.
Report scope:
|
Attribute |
Details |
|
Market Size 2024 |
US$ 2.5 Billion |
|
Projected Market Size 2034 |
US$ 11.9 Billion |
|
CAGR Growth Rate |
18.7% |
|
Base year for estimation |
2023 |
|
Forecast period |
2024 – 2034 |
|
Market representation |
Revenue in USD Million & CAGR from 2024 to 2034 |
|
Market Segmentation |
By Product - Consumables and Instruments By Application - Oncology, Developmental Biology, Drug Development, Metabolic Disorders, and Other By End-User - Academic & Research Institute, Pharmaceuticals & Biopharmaceutical Companies, and Contract Research Organization |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Epigenetics Market, By Product:
- Consumables
- Instruments
Epigenetics Market, By Application:
- Oncology
- Others
- Metabolic diseases
- Drug development
- Developmental biology
Epigenetics Market, By End-User
- Academic and research institute
- Contract research organizations
- Pharmaceuticals and biopharmaceutical companies
Epigenetics Market, By Region:
- North America
- Middle East & Africa
- Middle East & Africa Epigenetics Market, By Product
- Middle East & Africa Epigenetics Market, By Application
- Middle East & Africa Epigenetics Market, By End-User
- Middle East & Africa Epigenetics Market, By Country
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Latin America Epigenetics Market, By Product
- Latin America Epigenetics Market, By Application
- Latin America Epigenetics Market, By End-User
- Latin America Epigenetics Market, By Country
- Brazil
- Mexico
- Rest of Latin America
- Asia Pacific
- Asia Pacific Epigenetics Market, By Product
- Asia Pacific Epigenetics Market, By Application
- Asia Pacific Epigenetics Market, By End-User
- Asia Pacific Epigenetics Market, By Country
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Europe
- Europe Epigenetics Market, By Product
- Europe Epigenetics Market, By Application
- Europe Epigenetics Market, By End-User
- Europe Epigenetics Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- North America Epigenetics Market, By Product
- North America Epigenetics Market, By Application
- North America Epigenetics Market, By End-User
- North America Epigenetics Market, By Country
- U.S.
- Canada
- Middle East & Africa
Global Epigenetics Market By Product Key Players
Some of the prominent players operating in the global epigenetics market include Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited, Bio-Rad Laboratories, Inc., Qiagen Inc., Zymo Research Corporation, Diagenode S.A., Enzo Life Sciences, Inc. and New England Biolabs Inc. Advancements in the product as well as in manufacturing process, product launches, and strategic partnerships are some trends witnessed by the global epigenetics market. For instance, in 2015, Illumina, Inc. a company which provides sequencing and array-based solutions for genetic analysis collaborated with Merck Serono S.A to develop a universal next sequencing based oncology diagnostics.
Market Taxonomy:
This report segments the global epigenetics market on the basis of product, application, end user, and region. On the basis of product, the target market is classified into consumables and instruments. Based on application, the target market is bifurcated into oncology, developmental biology, drug development, metabolic diseases, and others. On basis of end user, the target market is categorized into academic and research institute, pharmaceuticals and biopharmaceutical companies, and contract research organizations.
Key features of the study:
Prophecy Market Insights provides detailed analysis on epigenetics market in our report- Global Epigenetics Market by product, application, end-user, and region. The report provides market size (US$ Mn) and compounded annual growth rate (%) for the forecast period: 2019 – 2029, considering 2018 as the actual year. The report also contains in-depth analysis about market drivers, restraints, opportunities, new product launches, product approval, ongoing trends, customers demand, and regional outlook. The report delivers competitive analysis about leading players in the global epigenetics market based on various parameters such as company overview, product portfolio, regional presence, financial performance, distribution strategies, key developments, marketing strategies, and future plans. The analysis from the report would acquaint the marketers and management authorities of companies to make the appropriate decision with respect to their future product launch, ongoing trends, market expansion, and marketing tactics used overall the globe. Various strategy matrices include in the report are PEST analysis, PORTER’s five forces analysis, and opportunity map analysis to analyze the epigenetics market.
Global Epigenetics Market By Product Company Profile
- Illumina Inc.*
- New England Biolabs Inc.
- Enzo Life Sciences, Inc.
- Diagenode S.A
- Zymo Research Corporation
- Qiagen Inc.
- Bio-Rad Laboratories, Inc.
- Merck Millipore Limited
- Thermo Fisher Scientific Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
Global Epigenetics Market By Product Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Preview
- Executive Summary
- Key Findings—Global Outlook for Epigenetic Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Application
- Market Snippet, By End-User
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Market Segmentation, By Product type, 2020 – 2030, (US$ Mn)
- Consumables
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Instruments
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Consumables
- Market Segmentation, By Application, 2020 – 2030, (US$ Mn)
- Oncology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Developmental Biology
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Drug Development
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Metabolic Disorder
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Others
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Oncology
- Market Segmentation, By End-User, 2020 – 2030, (US$ Mn)
- Academic & Research Institute
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Pharmaceuticals & Biopharmaceutical Companies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Contract Research Organization
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Academic & Research Institute
- Global Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Application, 2020 – 2030
- Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Illumina Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Thermo Fisher Scientific Inc
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Merck Millipore Limited
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Bio-Rad Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Qiagen Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Zymo Research Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Diagenode S.A
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Enzo Life Sciences, Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- New England Biolabs Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Performance
- Illumina Inc.
-
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
Global Epigenetics Market is segmented, By Product Type (Consumables and Instruments), By Application (Oncology, Developmental Biology, Drug Development, Metabolic Disorders, and Other), and By End User (Academic & Research Institute, Pharmaceuticals & Biopharmaceutical Companies, and Contract Research Organization)
Increasing research and development in the field of epigenetics is expected to foster the global epigenetics market.
Key players operating in the global market of epigenetics include Illumina Inc., Thermo Fisher Scientific Inc., Merck Millipore Limited, Bio-Rad Laboratories, Inc., Qiagen Inc., Zymo Research Corporation, Diagenode s. a., Enzo Life Sciences, Inc. and New England Biolabs Inc.